Appoints E. Lynne Kelley M.D. FACS
-
Biologics
Histogenics Corporation Appoints E. Lynne Kelley, M.D., FACS As Chief Medical Officer
WALTHAM, Mass., July 31, 2018 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell…
Read More »